GlassScriptPhysician profile
Eloisa M Correa
NPI 1740500149
$2,530.86
in general payments reported to CMS, 2019-2025
18 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $288 · 2021: $1,057 · 2022: $304 · 2023: $148 · 2024: $193 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $726.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $375.99 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $335.07 | 2021-2025 | Ozempic |
| Astrazeneca Pharmaceuticals LP | $252.18 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $232.48 | 2021-2022 | |
| Pfizer INC. | $191.33 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $190.06 | 2020-2022 | |
| Boston Scientific Corporation | $154.02 | 2019-2022 | |
| Glaxosmithkline, LLC. | $136.01 | 2021 | |
| Amarin Pharma, INC. | $130.78 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $95.02 | 2020-2021 | |
| Eisai INC. | $90.08 | 2020-2021 | |
| Hologic Sales and Service, LLC | $89.00 | 2023-2025 | Aptima |
| Insmed, INC. | $77.69 | 2021 | |
| Lilly USA, LLC | $49.97 | 2021-2022 | |
| Amgen INC. | $45.14 | 2025 | Repatha, Otezla |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $40.34 | 2020-2021 | |
| Abbott Laboratories | $29.40 | 2025 | Eterna |
| Genentech USA, INC. | $16.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eloisa Correa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.